Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43,411,663
-
Total 13F shares
-
10,554,208
-
Share change
-
+3,931,445
-
Total reported value
-
$167,568,706
-
Price per share
-
$15.88
-
Number of holders
-
60
-
Value change
-
+$63,118,277
-
Number of buys
-
42
-
Number of sells
-
14
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2019
As of 31 Dec 2019,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,554,208 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, Nantahala Capital Management, LLC, BlackRock Inc., Slate Path Capital LP, VANGUARD GROUP INC, MANGROVE PARTNERS, STATE STREET CORP, 683 Capital Management, LLC, Corriente Advisors, LLC, and Crestwood Advisors Group LLC.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.